U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2005. [_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM________ TO ________ Commission File Number 000-27592 TECH LABORATORIES, INC. (Exact name of Small Business issuer in its charter) New Jersey 22-1436279 ------------------------------- ------------------------------------ (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) In c/o Anslow & Jaclin, LLP, Attn: Gregg Jaclin 195 Route 9 South, Suite 204, Manalapan, NJ 07726 ---------------------------------------------- ----------------- (Address of principal executive offices) (zip code) Registrant's telephone number, including area code: (973) 427-5333 Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [_] Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes |_| No |X| The number of shares of Common Stock, par value $.01 per share, outstanding as of the latest practicable date: As of November 14, 2005, there were 127,155,216 shares outstanding. TECH LABORATORIES, INC. FORM 10-QSB TABLE OF CONTENTS PART I FINANCIAL INFORMATION Item 1. FINANCIAL STATEMENTS Balance Sheets................................................................... 1 - 2 Statements of Operations ........................................................ 3 Statements of Cash Flows......................................................... 4 - 5 Notes to Financial Statements.................................................... 6 - 7 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations............................................................ 8 Item 3. Controls and Procedures.......................................................... 9 PART II OTHER INFORMATION Item 1. Legal Proceedings................................................................. 10 Item 2. Changes in Securities............................................................. 10 Item 3. Defaults by the Company Upon its Senior Securities................................ 10 Item 4. Submission of Matters to a Vote of Security Holders............................... 10 Item 5. Other Information................................................................. 10 Item 6. Exhibits and Reports on Form 8-K.................................................. 10 SIGNATURES.......................................................................................... 11 Item 1. Financial Information BASIS OF PRESENTATION The accompanying reviewed financial statements are presented in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-QSB and item 310 under subpart A of Regulation S-B. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal occurring accruals) considered necessary in order to make the financial statements not misleading, have been included. Operating results for the nine months ended September 30, 2005 are not necessarily indicative of results that may be expected for the year ending December 31, 2005. The financial statements are presented on the accrual basis. TECH LABORATORIES, INC. BALANCE SHEETS ASSETS September 30, December 31, 2005 2004 (Unaudited) -------------------- ----------------- Current Assets: Cash $ 1,436 $ 106,283 Accounts receivable, net of allowance of $1,000 - 10,679 Inventories - 907,030 Prepaid expense 40,625 59,376 -------------------- ----------------- Total current assets 42,061 1,083,368 -------------------- ----------------- Certificate of deposit (restricted) - 36,499 -------------------- ----------------- Property, plant and equipment, at cost Leasehold improvements - 2,247 Machinery, equipment, and instruments - 608,917 Furniture and fixtures - 109,584 -------------------- ----------------- - 720,748 Less accumulated depreciation and amortization - 442,570 -------------------- ----------------- Net property, plant and equipment - 278,178 -------------------- ----------------- Other - 14,420 -------------------- ----------------- Total Assets $ 42,061 $ 1,412,465 ==================== ================= See notes to financial statements. 1 TECH LABORATORIES, INC. BALANCE SHEETS (UNAUDITED) LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) September 30, December 31, 2005 2004 (Unaudited) ----------------- ----------------- Current liabilities: Convertible notes $ 959,627 $ 828,885 Note payable 20,620 34,444 Accounts payable and accrued expenses 242,973 352,457 ----------------- ----------------- Total current liabilities 1,223,220 1,215,786 ----------------- ----------------- Stockholders' equity: Common stock, $.01 par value; 195,000,000 shares authorized: 127,155,216 shares issued in 2005; 88,161,612 shares issued in 2004 1,271,552 881,616 Less: 15,191 shares reacquired and held in treasury (113) (113) ----------------- ----------------- 1,271,439 881,503 Capital contributed in excess of par value 4,829,634 5,417,562 Accumulated deficit (7,282,232) (6,102,386) ----------------- ----------------- Total stockholders' equity (1,181,159) 196,679 ----------------- ----------------- Total liabilities and stockholders' equity $ 42,061 $ 1,412,465 ================= ================= See notes to financial statements. 2 TECH LABORATORIES, INC. STATEMENTS OF OPERATIONS (UNAUDITED) For the For the Three Months Ended Nine Months Ended September 30, September 30, ------------------------------------ ------------------------------------ 2005 2004 2005 2004 ----------------- ---------------- ------------------ ---------------- Sales $ - $ 167,872 $ 91,280 $ 233,138 ----------------- ---------------- ------------------ ---------------- Costs and expenses: Cost of sales - 92,179 30,557 131,043 Selling, general, and administrative expense 23,447 181,065 273,514 491,138 ----------------- ---------------- ------------------ ---------------- 23,447 273,244 304,071 622,181 ----------------- ---------------- ------------------ ---------------- Income (loss) from Operations (23,447) (105,372) (212,791) (389,043) ----------------- ---------------- ------------------ ---------------- Other income (expenses): Other expense (17,614) (8,742) (82,481) (397,383) Loss on settlement agreement (Note 2) (884,574) - (884,574) - ----------------- ---------------- ------------------ ---------------- (902,188) (8,742) (967,055) (397,383) ----------------- ---------------- ------------------ ---------------- Income (loss) before income taxes (925,635) (114,114) (1,179,846) (786,426) Provision for income taxes - - - - ----------------- ---------------- ------------------ ---------------- Net income (loss) (925,635) (114,114) (1,179,846) (786,426) (Accumulated deficit), Beg Qtr. (6,356,597) (5,415,388) (6,102,386) (4,743,076) ----------------- ---------------- ------------------ ---------------- (Accumulated deficit), End Qtr. (7,282,232) (5,529,502) (7,282,232) (5,529,502) ----------------- ---------------- ------------------ ---------------- Net loss per share, basic and diluted $ (0.01) $ - $ (0.01) $ (0.02) ================= ================ ================== ================ Weighted average number of common shares and equivalents, basic and diluted 139,926,344 65,324,970 119,817,514 46,557,417 ================= ================ ================== ================ See notes to financial statements. 3 TECH LABORATORIES, INC. STATEMENTS OF CASH FLOWS (UNAUDITED) Nine Months Ended September 30, ------------------------------------- 2005 2004 ------------------ ----------------- Cash flow from (for) operating activities: Net (loss) from operations $(1,179,846) $ (786,426) Add (deduct) items not affecting cash: Depreciation/amortization 9,774 14,661 Loss on settlement agreement 884,574 - Capitalized interest 30,742 - Expenses paid with the issuance of stock - 743,741 Changes in operating assets and liabilities Accounts receivable (862) (94,704) Inventories (165,312) (206,345) Accounts payable and accrued expenses 115,348 25,628 Other assets/liabilities 18,751 2,347 ------------------ ----------------- Net cash flow for operating activities (286,831) (301,098) ------------------ ----------------- Cash flows from (for) investing activities Decrease in restricted certificate of deposit 1,364 - ------------------ ----------------- Net cash flow from (for) investing activities 1,364 - ------------------ ----------------- Cash flows from (for) financing activities: Proceeds of convertible note 160,000 175,000 Proceeds from notes payable 20,620 - ------------------ ----------------- Net cash flow from (for) financing activities 180,620 175,000 ------------------ ----------------- Net increase (decrease) in cash (104,847) (126,098) Cash balance beginning of year 106,283 165,308 ------------------ ----------------- Cash balance - end of third quarter $ 1,436 $ 39,210 ================== ================= Supplemental schedule of noncash investing and financing activities: Conversion of debt to common stock $ 60,000 $ 1,538,837 See notes to financial statements. 4 TECH LABORATORIES, INC. NOTES TO FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 2005 (UNAUDITED) 1. BASIS OF PRESENTATION The accompanying unaudited financial statements of Tech Laboratories, Inc. ("the Company") have been prepared in accordance with generally accepted accounting principles for interim financial information and with Item 310(b) of Regulation SB. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended, September 30, 2005 are not necessarily indicative of the results that may be expected for the year ended December 31, 2005. These unaudited financial statements should be read in conjunction with the audited financial statements and footnotes thereto included in the Company's Form 10-KSB for the year ended, December 31, 2004, as filed with the Securities and Exchange Commission. Certain prior year balances have been reclassified to conform to the current year presentation. 2. SETTLEMENT AGREEMENT AND RELEASE On July 11, 2005, (the "Effective Date"), the Company finalized a Settlement Agreement and Release (the "Agreement") with Bernard Ciongoli and Earl Bjorndal (the "Settlement Parties"). In connection with the Agreement, Mr. Ciongoli resigned from his positions as President, Chief Executive Officer, Chief Financial Officer and member of the Board of Directors of the Company, and agreed to the cancellation of 17,754,806 of his shares of our common stock. Earl Bjorndal resigned from his positions as Vice President and member of the Board of Directors of the Company, and agreed to the cancellation of 8,044,445 of his shares of our common stock. The parties agreed to the transfer of all of the Company's assets, including all technologies and product lines, to the Settlement Parties in exchange for the cancellation of all outstanding obligations owed to the Settlement Parties, including past due salaries and loans due to them, the cancellation of the above mentioned shares, and the assumption of certain liabilities of the Company and the lease by the Settlement Parties. The Agreement grants the Company a seven-year license in the transferred technology, pursuant to which the Company shall have the right to sell the products developed for the DynaTrax technology as a dealer to its customers at a dealer price of 25% off list price. The Company will also receive a royalty of 5% of the profits per year for the sale of DynaTrax products. The Company recorded a loss from this transaction in the amount of $884,574. 3. LONG-TERM CONVERTIBLE DEBT On October 13, 2000, Tech Labs completed a $1.5 million financing of 6.5% convertible promissory notes due October 15, 2002. Interest is payable quarterly in cash or in shares of common stock at the option of the noteholders. Tech Labs disclosed all terms of this financing on Form 8-K filed on October 18, 2000. As of June 30, 2005, $986,913 of principal and interest on the 6.5% convertible notes has been converted into shares of Tech Labs' common stock. On January 11, 2002, Tech Labs entered into a conversion and redemption agreement concerning this long-term debt. An Event of Default, as defined in the 6.5% convertible notes, occurred on January 25, 2002, when Tech Labs was unable to make the first payment of $750,000 to the holders of the notes. 5 TECH LABORATORIES, INC. NOTES TO FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 2005 (UNAUDITED) 3. LONG-TERM CONVERTIBLE DEBT (Cont'd) On April 19, 2002, Tech Labs successfully negotiated a cure of the default referenced above. This cure required that Tech Labs' registration statement, filed with the Securities and Exchange Commission on April 5, 2002, covering the shares underlying the 6.5% convertible notes, to have been declared effective on or before June 29, 2002. If the registration statement was declared effective by such date and Tech Labs made certain payments described in the Tech Labs' report on Form 8-K filed April 25, 2002, the maturity date of the 6.5% convertible notes would have been extended from October 13, 2002 to December 30, 2002. On August 2, 2002, the Company announced that an Event of Default occurred on the 6.5% convertible notes. The Company was unable to have its registration statement declared effective by June 29, 2002, and was unable to reach a new agreement with the holders of the 6.5% convertible notes prior to the expiration of the waiver the Company had been granted by the holders of the notes, which had been granted in order to permit the parties time to negotiate a new agreement. The Company continued to seek a cure for the default with the holders of the 6.5% convertible notes, and in October 2003, a cure was successfully negotiated and is described in the Company's 8-K filed in October, 2003. On May 18, 2004, the Company issued an additional $250,000 convertible debenture at a rate of 5.0% due on May 18, 2007. On April 22, 2005, the convertible debt of $250,000 was renegotiated with an additional $160,000 plus accrued interest for a total amount of $420,514. The interest rate is 5% per annum and is due upon demand. In connection with this transaction, the Company issued 50,000,000 shares of common stock to be held in escrow, as collateral, for the transaction. On April 22, 2005, the Company issued warrants to Montgomery Equity Partners, Ltd. to purchase 100,000 shares of common stock at the par value of $.0001 per share. 6 Item 2. Management's Discussion and Analysis or Plan of Operation We were incorporated in 1947 as a New Jersey corporation. Our focus has historically been the design, manufacture, and sale of rotary switches. Switches have been a significant part of our revenue for five decades. In 1995, to augment revenues, we sought business in transformers and contract manufacturing. In 1998, we made a shift to new product development. In 1998, we also made our first sales of the IDS product, and in April of 1999, we completed the acquisition of the DynaTraX(TM) switch and technology. DynaTraX(TM) is a high-speed digital switch matrix system, an electronic switching unit for network management and security. This equipment manages video and data transmissions on a network. On July 11, 2005 (the "Effective Date"), the Company finalized a Settlement Agreement and Release (the "Agreement") with Bernard Ciongoli and Earl Bjorndal (the "Settlement Parties"). In connection with the Agreement, Mr. Ciongoli resigned from his positions as President, Chief Executive Officer, Chief Financial Officer, and member of the Board of Directors of the Company, and agreed to the cancellation of 17,931,806 of his shares of our common stock. Earl Bjorndal resigned from his positions as Vice President and member of the Board of Directors of the Company, and agreed to the cancellation of 8,044,445 of his shares of our common stock. The parties agreed to the transfer of all of the Company's assets, including all technologies and product lines, to the Settlement Parties in exchange for the cancellation of all outstanding obligations owed to the Settlement Parties, including past due salaries and loans due to them, the cancellation of the above mentioned shares, and the assumption of certain liabilities of the Company and the lease by the Settlement Parties. As part of the Agreement, we agreed to transfer of all of the issued and outstanding shares of common stock of Tech Logistics, Inc., our subsidiary to Bernard Ciongoli. Pursuant to the Agreement, the Settlement Parties granted the Company a seven year license in the transferred technology, pursuant to which the Company shall have the right to sell the products developed from the DynaTraX technology as a dealer to its customers at a dealer price of 25% off list price. The Company will also receive a royalty of 5% of the profits per year for the sale of DynaTrax products. In exchange for all of the Company's assets, the Settlement Parties agreed to the cancellation of all outstanding obligations owed to the Settlement Parties, including past due salaries and loans due to them; the cancellation of the above mentioned shares; and the assumption of certain liabilities of the Company and the lease by the Settlement Parties. On July 11, 2005, Bernard Ciongoli resigned from his positions as President, Chief Executive Officer, Chief Financial Officer, and member of the Board of Directors of the Company. Also on July 11, 2005, Earl Bjorndal resigned from his positions as Vice President and member of the Board of Directors of the Company. Such resignation was in accordance with the terms of an Agreement and is not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practice. On July 11, 2005, Donna Silverman was appointed as the Company's President, Chief Executive Officer, and Chief Financial Officer and to the Board of Directors of the Company. We are now seeking a merger candidate for the purpose of a merger. Although we have begun preliminary negotiations with several candidates, we have not entered into any letters of intent to date. Quarter ending September 30, 2005, compared to Quarter ending September 30, 2004 -------------------------------------------------------------------------------- See Note 2 to the financial statements regarding the settlement agreement and release. There were no sales during the third quarter of 2005. Selling, general, and administrative expenses decreased by $157,618 compared to the same period of 2004 due to decreases in selling expenses, and expenses associated with the company's attempts to raise long-term capital due to the successful completion of the stand by equity agreement and the settlement agreement. 9 Net loss from operations of $925,635 increased $811,521 compared to a loss of $114,114 for the prior period as a direct result of the settlement agreement during the third quarter 2005. Nine Months Ending September 30, 2005 Compared to Nine Months Ending September 30, 2004 Sales were $91,280 for the nine months ended, September 30, 2005, as compared to $233,138 for the similar period of 2004. The decrease was primarily due to no sales occurring during the third quarter of 2005. Cost of sales of $30,557 for the nine months ended September 30, 2005 decreased by $100,486 compared to the same period of 2004, primarily due to the reduction in sales. Selling, general, and administrative expenses decreased by $217,624 compared to the same period of 2004 due to the curtailment of marketing activities and the settlement agreement. Loss from operations of $1,179,846 increased $393,420 compared to a loss of $786,426 for the prior period as a result of the reduction in sales and the settlement agreement. SIGNIFICANT CHANGES None LIQUIDITY AND CAPITAL RESOURCES The Company's operating activities utilized cash of $286,831 during the nine months ended, September 30, 2005, as compared to $301,098 during the nine months ended, September 30, 2004. As a result of the continuing operating losses and negative cash flow experienced during 2003, 2004 and the nine months of 2005, Tech Labs has a tenuous liquidity position. If sales do not improve or alternative financing is not obtained, substantial doubt exists about Tech Labs' ability to continue as a going concern. SUBSEQUENT EVENTS On October 13, 2005, we were informed by the State of New Jersey, Department of the Treasury that we were delinquent in filing certain Sales Tax Returns and Employer Withholding Tax Returns. Our charter will not be reinstated with the State of New Jersey until all such returns have been filed. We are currently working with our accountant to complete such returns in a timely fashion. Item 3. Controls and Procedures (a) Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Chief Financial Officer (collectively the "Certifying Officers") maintain a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management timely. Under the supervision and with the participation of management, the Certifying Officers evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule [13a-14(c)/15d-14(c)] under the Exchange Act) within 90 days prior to the filing date of this report. Based upon that evaluation, the Certifying Officers concluded that our disclosure controls and procedures are effective in timely alerting them to material information relative to our company required to be disclosed in our periodic filings with the SEC. 10 (b) Changes in internal controls. Our Certifying Officers have indicated that there were no significant changes in our internal controls or other factors that could significantly affect such controls subsequent to the date of their evaluation, and there were no such control actions with regard to significant deficiencies and material weaknesses. PART II - OTHER INFORMATION Item 1. Legal Proceedings. On July 31, 2002, Tawfik Khalil and Amneh Khalil filed a lawsuit in the Superior Court of Passaic County, New Jersey, against Glen Venza, a Company part-time employee, Tech Labs, and certain other parties for property damages and personal injuries. The case arose from a car accident involving Mr. Venza and the plaintiffs, which occurred while Mr. Venza was performing certain duties for Tech Labs in a vehicle Mr. Venza borrowed from a third party. Tech Labs has only been named as a party to the personal injuries, and not for property damages, and believes it is covered for the accident by its insurance policy. On July 30, 2003, a former director and a former employee filed a joint lawsuit in Superior Court of New Jersey, Passaic County, against us for consulting fees and expenses, respectively. In the same lawsuit, W.T. Sports filed a claim for a commission owed on sales due from a licensing agreement with us. The claims by the former director and former employee are for about $10,000 and we deny any liability under these claims and are defending the lawsuit. With regard to W.T. Sports, our agreement has an arbitration in case of dispute and therefore we are attempting to move this case to arbitration. We believe that we have a counterclaim, which is far in excess of the amount they claim we owe for the licensing fees. On November 11, 2004, an arbitration hearing took place. On December 31, 2004, the arbitrator awarded $35,148 to WT Sports. Tech Labs can continue to manufacture the system in the United States.We are currently attempting to negotiate a settlement with W.T. Sports. On June 30, 2004, the law firm of Stursberg & Veith, former counsel to Tech Laboratories, Inc., filed a lawsuit in the United States District Court for the Southern District of New York claiming that the plaintiff delivered certain good and valuable services to Tech laboratories and is owed $161,179.26 plus interest, costs, and disbursements for each cause of action, and other and further relief as the Court may deem necessary. The complaint alleges four causes of action including an unpaid account, stated breach of contract, quantim meruit, and unjust enrichment. We disagree with the amount of the unpaid balance owed to the plaintiff. We have filed a counterclaim for overcharging by the plaintiff.Stursberg & Veith have filed a motion for summary judgment; however, we are currently trying to negotiate a settlement with them. Item 2. Changes in Securities. On July 11, 2005 (the "Effective Date"), the Company finalized a Settlement Agreement and Release (the "Agreement") with Bernard Ciongoli and Earl Bjorndal (the "Settlement Parties"). In connection with the Agreement, Mr. Ciongoli resigned from his positions as President, Chief Executive Officer, Chief Financial Officer, and member of the Board of Directors of the Company, and agreed to the cancellation of 17,931,806 of his shares of our common stock. Earl Bjorndal resigned from his positions as Vice President and member of the Board of Directors of the Company, and agreed to the cancellation of 8,044,445 of his shares of our common stock. Item 3. Defaults Upon Senior Securities. Not Applicable. Item 4. Submission of Matters to a Vote of Security Holders. A 14C Information Statement was filed on September 6, 2005, informing the shareholders that the Majority Stockholders approved the Settlement Agreement and Release by and among the Company, Bernard Ciongoli and Earl Bjorndal, our former officers and directors. 11 Item 5. Other Information. None. Item 6. Exhibits and Reports of Form 8-K On July 18, 2005, the Company filed an 8K pursuant to the execution of the Settlement Agreement and Release by and among the Company, Bernard Ciongoli and Earl Bjorndal, our former officers and directors. 12 TECH LABORATORIES, INC. SIGNATURES In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, there unto duly authorized. Date: November 14, 2005 TECH LABORATORIES, INC. By: /s/ Donna Silverman ------------------- Donna Silverman Chief Executive Officer, Chief Financial Officer and President